Multidrug resistance (MDR) is a phenomenon where microorganisms exhibit resistance to multiple antimicrobial drugs. This poses a significant challenge in the treatment of various infectious diseases, as commonly used antibiotics become ineffective against the resistant strains. MDR is a complex and evolving problem that arises due to the overuse and misuse of antimicrobial agents. The mechanisms behind multidrug resistance are diverse and often involve genetic changes in microorganisms. One common mechanism is the overexpression of efflux pumps, which actively pump out antibiotics from the bacterial cell, reducing their concentration and efficacy. Additionally, bacteria can acquire resistance genes through horizontal gene transfer, allowing them to adapt and survive exposure to multiple drugs. The misuse of antimicrobials in both clinical and agricultural settings accelerates the development of multidrug resistance. Inappropriate prescribing practices, patient non-compliance, and the widespread use of antibiotics in livestock contribute to the emergence of resistant strains. This not only limits treatment options for infectious diseases but also raises concerns about the potential for a post-antibiotic era where common infections become untreatable. Addressing multidrug resistance requires a multifaceted approach. This includes promoting judicious use of antimicrobials, developing new and innovative therapeutic strategies, and implementing stringent regulations to control the use of antibiotics. Surveillance of antibiotic resistance patterns, both locally and globally, is crucial for understanding the scope of the problem and devising effective interventions.